exv10w2






Exhibit 10.2




AMENDMENT NO. 1 TO

DISTRIBUTION AGREEMENT




     THIS AMENDMENT NO. 1 TO DISTRIBUTION AGREEMENT (this “Amendment No. 1”), effective as of
January 1, 2006 (the “Amendment Effective Date”), is entered into between FISHER SCIENTIFIC
COMPANY L.L.C., a Delaware limited liability company represented by its FISHER HEALTHCARE division,
(“FHC”), having a place of business at 9999 Veterans Memorial Drive, Houston, Texas 77038, and
BIOSITE INCORPORATED, a Delaware corporation (“Biosite”), having a place of business at 9975
Summers Ridge Road, San Diego, California 92121. Capitalized terms not defined herein shall have
the meanings set given to them in the Agreement.



RECITALS




     A. The
parties have entered into a Distribution Agreement effective as of
January 1, 2006 (the “Agreement”).


     B. The
parties now desire to amend the Agreement in certain respects on the
terms and conditions set forth below.


     NOW THEREFORE, in consideration of the foregoing premises and the mutual covenants set
forth below, the parties amend the Agreement and otherwise agree as follows:



     1. Amendments.


          1.1 Notwithstanding anything to the contrary in the Agreement, including
without limitation Sections 2(c) and 2(d), the “Territory” shall exclude Puerto Rico and the
US Virgin Islands.


     Accordingly, the first sentence of Section 2(c) is hereby amended and restated to
read as follows:


     “The “Territory” consists of two segments in the United States and its territories
(excluding Puerto Rico and the US Virgin Islands): (1) the “Hospital Medical Segment”, and
(2) the “Physician Medical Segment.”


     In addition, in the fourth sentence of Section 2(d), each reference to the phrase
“United States and its territories (including without limitation, Puerto Rico” shall be
hereafter replaced with the phrase “United States and its territories (excluding Puerto Rico
and the US Virgin Islands)”.


          1.2 Notwithstanding anything to the contrary in the Agreement, except with
respect to sales to customers in the Territory who have purchased any of the Products listed
on the attached Exhibit A (the “SOB Products”)
on or prior to March 31, 2006 ( “Pre-existing SOB
Product Customers”), the SOB Products shall be considered Increased Margin Products in the
Territory, and the “first sale of such Product by Biosite to FHC” under the Agreement shall be
deemed to have occurred on the Effective Date. For the avoidance of doubt any sales of SOB


1








 







Products
to Pre-existing SOB Product Customers, at any time, shall be deemed sales of Cardiac
Products as originally contemplated by the Agreement and the GSMR for sales of such Cardiac
Products shall be 11%. By not later than April 30, 2006, Biosite and Fisher shall mutually agree
to a list of those Pre-existing SOB Product Customers based on their respective business records.




     2. Miscellaneous.


          2.1
Continuing Effect. This Amendment No. 1 shall be effective for all
purposes as of the Amendment Effective Date. Except as otherwise expressly modified by this
Amendment No. 1, the Agreement shall remain in full force and effect in accordance with its
terms.




          2.2
Governing, Laws. This Amendment No. 1 shall be governed by,
interpreted and construed in accordance with the laws of the State of California, without regard to
conflicts of law principles.




          2.3
Counterparts. This Amendment No. 1 may be executed in counterparts,
each of which shall be deemed to be an original and together shall be deemed to be one and the
same document.




     IN WITNESS WHEREOF, the parties have caused this Amendment No. 1
to be executed by their
respective duly authorized officers as of the Amendment Effective Date.



	 	 	 	 	 	 	 	 	 	 	 
	BIOSITE INCORPORATED	 	 	 	FISHER SCIENTIFIC COMPANY L.L.C.
	 
	 	 	 	 	 	 	 	 	 	 
	     By:
	 	/s/ Robert B. Anacone	 	 	 	     By:	 	/s/ Kirk Kimler	 	 
	 

	 	 

	 	 	 	 	 	 

	 	 
	     Title:
	 	Sr VP, WW Marketing and Sales	 	 	 	     Title:	 	President & General Manager	 	 






2









 





EXHIBIT A


SOB PRODUCTS



	 	 	 	 	 	 	 
	Catalog	 	 	 	 	 	 
	Number	 	Product	 	Size	 	List Price
	97300
	 	Triage ProfilER SOB Panel	 	25 tests	 	$1,175.00
	97301
	 	Triage ProfilER SOB Control Set (2x1)	 	 	 	$   100.00
	97303
	 	Triage ProfilER SOB Control Set (5x1)	 	 	 	$   100.00
	97305
	 	Triage ProfilER SOB Calibration Verification Samples	 	 	 	$     80.00







3